Telomir Pharmaceuticals, Inc. (TELO): Company Cash Volume

Official company branding of Telomir Pharmaceuticals Corp (TELO)

Telomir Pharmaceuticals (TELO) is betting on the development of cellular regeneration and anti-aging treatments. The cash reserve indicator reflects liquidity dynamics, with the latest parameter standing at 0.00. As part of its ESG agenda, the firm is implementing biodegradable packaging and safe chemical disposal. However, the preclinical status of its projects and a lack of revenue create a risk of critical capital deficiency.

Company Cash Balance: Telomir Pharmaceuticals Corp (TELO) for 02/21/2024 - 11/21/2026

Telomir Pharmaceuticals, Inc. - analytical breakdowns and key metrics (TELO)

- stock value and consensus price forecast:
Fundamental valuation:Telomir Pharmaceuticals Corp
Signature product of telomirpharma.com

Institutional capital evaluates Telomir Pharmaceuticals (TELO) through the lens of financial stability, where a sufficient liquidity reserve is critical for the long-term funding of research and development in telomere regulation. An analysis of the cash position reflects the dynamics of available monetary resources to cover operating expenses and debts, confirming the company's ability to develop its longevity ecosystem without the risk of sudden insolvency.

Analysis of competing companies

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance